From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 3,250,193 shares, representing 3.23% for $12 million under the buyback announced on November 4, 2020.
BioDelivery Sciences International, Inc.
Equities
BDSI
US09060J1060
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+20.81% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.39% | 198B | |
-10.47% | 194B | |
+8.08% | 167B |